Valtecne S.p.A., the Industrials sector company, was revisited by a Wall Street analyst yesterday. Analyst Gianluca Mozzali from Corporate Family Office SIM maintained a Buy rating on the stock and has a €10.00 price target.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Gianluca Mozzali has given his Buy rating due to a combination of factors linked to Valtecne’s solid start to the year and its positioning in core markets. The company reported close to €10.3m in preliminary Q1-26 revenues, showing high single-digit growth overall, with its Medical Devices segment expanding ahead of the underlying orthopaedics market and now representing roughly three quarters of group sales, in line with its strategic pivot toward MedTech.
Alongside this, the Industrial division has returned to growth, benefiting from improving end-markets and supporting operating leverage, even if it is not considered strategic in the long term. Management’s commercial initiatives, including the pipeline developed under the new commercial leadership and the ongoing integration of Utilità, are expected to sustain high-single-digit revenue growth and better margins, justifying a reiterated Buy stance and an unchanged €10 price target.